Quality of Life After Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection in Stage I/II Breast Cancer Patients: A Prospective Longitudinal Study

BackgroundBreast cancer patients’ quality of life (QoL) after surgery has been reported to improve significantly over time. Little is known about QoL recovery after sentinel lymph node biopsy (SLNB) in comparison to axillary lymph node dissection (ALND).Methods175 of 195 stage I/II breast cancer patients completed the EORTC QLQ-C30: one day before surgery (T0) and after 6 (T1), 26 (T2), 52 (T3) and 104 (T4) weeks. Of these, 54 patients underwent SLNB, 56 SLNB+ALND and 65 ALND. General linear models and paired T-tests between T0–T4 and T1–T4 were computed. Complications, radiotherapy and systemic therapy were added to the model.ResultsSignificant time effects were found on physical, role and emotional functioning. Physical and role functioning decreased between T0 and T1. At T4, SLNB patients’ functioning had increased to their T0 level; ALND (+/– SLNB) patients’ functioning had increased, but had not improved to T0 level. Emotional functioning increased linearly between T0 and T4. At T4, emotional functioning was significantly higher in all groups as compared with T0. No significant group or interaction (time × group) effects were found. Complications and chemotherapy had a significant negative effect on role, emotional and cognitive functioning. Complications had a significant effect on social functioning also. Effect sizes varied between 0.00 and 0.06.ConclusionTwo years post surgery, breast cancer patients’ QoL is comparable to that shortly before surgery. Women rated their emotional functioning as even better. SLNB is not associated with a better QoL than ALND. However, undergoing systemic therapy and/or experiencing complications affects QoL negatively.

[1]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[2]  V. Helgeson,et al.  Surviving cancer: A comparison of 5‐year disease‐free breast cancer survivors with healthy women , 2005, Psycho-oncology.

[3]  F. Peintinger,et al.  Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients , 2003, British Journal of Cancer.

[4]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[5]  W. Kwan,et al.  Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Hollenbeck,et al.  Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. , 2002, American journal of surgery.

[7]  D. Nitti,et al.  Clinical impact of false-negative sentinel lymph nodes in breast cancer. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  A. Bezjak,et al.  Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[9]  T. Julian,et al.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.

[10]  L. Bernstein,et al.  Influence of exercise activity on quality of life in long-term breast cancer survivors , 2005, Quality of Life Research.

[11]  D. Buist,et al.  Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49 , 2004, Health and Quality of Life Outcomes.

[12]  M. Groenvold,et al.  Health-related quality of life in long-term breast cancer survivors: Nationwide survey in Denmark , 2007, Breast Cancer Research and Treatment.

[13]  S. Duffy,et al.  Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Darai,et al.  Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer , 2005, Journal of surgical oncology.

[15]  Sheryl G. A. Gabram,et al.  Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial , 2006, Annals of Surgical Oncology.

[16]  J. Coebergh,et al.  Quality of life among long-term breast cancer survivors: a systematic review. , 2005, European journal of cancer.

[17]  A. Saykin,et al.  Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[19]  C. Carver,et al.  Quality of life among long‐term survivors of breast cancer: different types of antecedents predict different classes of outcomes , 2006, Psycho-oncology.

[20]  Umberto Veronesi,et al.  Sentinel‐Node Biopsy to Avoid Axillary Dissection in Breast Cancer with Clinically Negative Lymph‐Nodes , 1998 .

[21]  J. Donohue,et al.  Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. , 2003, Archives of surgery.

[22]  M. Espié,et al.  Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy , 2000, British Journal of Cancer.

[23]  Desmond Curran,et al.  EORTC QLQ-C30 Scoring Manual (2nd edition) , 1999 .

[24]  R. Newcombe,et al.  Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer , 2006, Breast Cancer Research and Treatment.

[25]  H. D. de Koning,et al.  Decreased rates of advanced breast cancer due to mammography screening in The Netherlands , 2004, British Journal of Cancer.

[26]  M. Rezvani,et al.  Shoulder movement after the treatment of early stage breast cancer. , 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

[27]  Jacqueline Kerr,et al.  Quality of Life Following Breast‐Conserving Therapy or Mastectomy: Results of a 5‐Year Prospective Study , 2004, The breast journal.

[28]  J. Brisson,et al.  Type of mastectomy and quality of life for long term breast carcinoma survivors , 1998, Cancer.

[29]  A. Giuliano,et al.  Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.

[30]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  P. Dijkstra,et al.  Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer , 2004, Annals of Surgical Oncology.

[32]  E. Rutgers,et al.  Technique of sentinel node biopsy in breast cancer. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[33]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[34]  A. Giuliano,et al.  The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer. , 1999, Advances in surgery.

[35]  D. Irvine,et al.  Psychosocial adjustment in women with breast cancer , 1991, Cancer.

[36]  C. Julian‐Reynier,et al.  Patients' and surgeons' perspectives on axillary surgery for breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[37]  V. Helgeson,et al.  Five years later: a cross‐sectional comparison of breast cancer survivors with healthy women , 2002, Psycho-oncology.

[38]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[39]  P. Ganz,et al.  Breast cancer in younger women: reproductive and late health effects of treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[41]  Jacob Cohen.  Statistical Power Analysis , 1992 .

[42]  P. Ganz,et al.  Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. , 2002, Journal of the National Cancer Institute.

[43]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  R. Kreienberg,et al.  Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[45]  J. Haviland,et al.  The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). , 2007, Breast.

[46]  P. Ganz,et al.  Quality of life of African‐American and white long term breast carcinoma survivors , 1999, Cancer.

[47]  Mark C Kelley,et al.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.

[48]  P. Del Bianco,et al.  Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[49]  Mary J. Nissen,et al.  Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer , 2002, Annals of Surgical Oncology.

[50]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[51]  H. D. de Koning,et al.  Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality , 2004, British Journal of Cancer.

[52]  Andreas Shamiyeh,et al.  Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma , 2000, Cancer.